Progesterone Tapering Protocol
Simply reduce the dose directly from 200 mg to 100 mg without a gradual taper. There is no evidence supporting a gradual dose reduction for oral micronized progesterone, and abrupt dose changes are standard practice in hormone replacement therapy protocols.
Rationale for Direct Dose Reduction
The available evidence demonstrates that progesterone dosing in hormone replacement therapy is adjusted based on the concurrent estrogen dose and the desired clinical effect (endometrial protection vs. withdrawal bleeding patterns), not through gradual tapering 1.
Standard Dosing Protocols
According to established guidelines for hormone replacement therapy:
- Sequential regimens use 200 mg of oral micronized progesterone for 12-14 days every 28 days when combined with continuous estrogen 1
- Continuous regimens require lower doses, with 100 mg daily being a standard maintenance dose 2
- Dose adjustments are made directly without intermediate steps 3
The 2021 Blood Reviews guidelines specifically outline that progesterone doses depend on the estrogen administered and the regimen type (sequential vs. continuous), with no mention of tapering protocols when changing doses 1.
Practical Implementation
Make the switch immediately:
- Stop taking 200 mg
- Begin taking 100 mg the next scheduled dose
- Continue taking at bedtime to minimize any drowsiness or dizziness 4, 5
Clinical Context Matters
The appropriateness of reducing from 200 mg to 100 mg depends on your specific situation:
If you're on sequential therapy (progesterone for 12-14 days per month): The 200 mg dose is standard and provides optimal endometrial protection. Reducing to 100 mg may be insufficient unless your estrogen dose is also being reduced 1.
If you're switching to continuous therapy (progesterone every day): The 100 mg daily dose is appropriate and has been shown to effectively protect the endometrium while inducing amenorrhea in over 90% of women 2.
Important Caveats
- Endometrial protection is dose-dependent: Research shows that 100 mg daily for 25 days per month provides adequate endometrial protection by fully inhibiting mitoses 2, but this is in the context of continuous administration
- Sequential regimens typically require 200 mg for the 12-14 day period to ensure complete endometrial protection 1, 3, 1
- Monitor for breakthrough bleeding: Any unexpected vaginal bleeding after dose reduction warrants endometrial evaluation 3
The FDA labeling for micronized progesterone confirms that doses of 100 mg and 200 mg are both standard formulations used in clinical practice, with no special instructions for transitioning between doses 4.
Consult your prescribing physician before making this change to ensure the 100 mg dose is appropriate for your specific hormone replacement regimen and clinical indication, as inadequate progesterone dosing can lead to endometrial hyperplasia.